RBC Capital raised the firm’s price target on Aveanna (AVAH) to $11 from $10 and keeps a Sector Perform rating on the shares. At an industry event yesterday, the company raised its 2025 adjusted EBITDA guidance and introduced 2026 guidance that exceeded consensus expectations, driving a 10% jump in shares, and the firm has come away incrementally more confident in Aveanna’s positioning given a confident tone from management around the company’s ability to meet growth targets ahead of more modest rate updates, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVAH:
- Aveanna price target raised to $10 from $9.50 at UBS
- Midday Fly By: Big banks report mixed quarterly results
- Aveanna Healthcare Raises 2025 Outlook, Issues 2026 Guidance
- Aveanna raises FY25 revenue view to $2.425B-$2.445B from more than $2.375B
- Aveanna sees FY26 revenue $2.54B-$2.56B, consensus $2.57B